|
1
|
Osherov AB, Gotha L, Cheema AN, Qiang BP
and Strauss BH: Proteins mediating collagen biosynthesis and
accumulation in arterial repair: Novel targets for anti-restenosis
therapy. Cardiovasc Res. 91:16–26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rodriguez-Menocal L, St-Pierre M, Wei Y,
Khan S, Mateu D, Calfa M, Rahnemai-Azar AA, Striker G, Pham SM and
Vazquez-Padron RI: The origin of post-injury neointimal cells in
the rat balloon injury model. Cardiovasc Res. 81:46–53. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Yang S, Wennmann DO, Chen Y,
Kremerskothen J and Dong J: KIBRA: In the brain and beyond. Cell
Signal. 26:1392–1399. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buttitta LA and Edgar BA: How size is
controlled: From hippos to yorkies. Nat Cell Biol. 9:1225–1227.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan D: Hippo signaling in organ size
control. Genes Dev. 21:886–897. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mo JS, Park HW and Guan KL: The Hippo
signaling pathway in stem cell biology and cancer. EMBO Rep.
15:642–656. 2014.PubMed/NCBI
|
|
7
|
Dong J, Feldmann G, Huang J, Wu S, Zhang
N, Comerford SA, Gayyed MF, Anders RA, Maitra A and Pan D:
Elucidation of a universal size control mechanism in Drosophila and
mammals. Cell. 130:1120–1133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harvey KF, Zhang X and Thomas DM: The
Hippo pathway and human cancer. Nat Rev Cancer. 13:246–257. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han Q, Lin X, Zhang X, Jiang G, Zhang Y,
Miao Y, Rong X, Zheng X, Han Y, Han X, et al: WWC3 regulates the
Wnt and Hippo pathways via Dishevelled proteins and large tumour
suppressor 1, to suppress lung cancer invasion and metastasis. J
Pathol. 242:435–447. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Doherty TM, Shah PK and Rajavashisth TB:
Cellular origins of atherosclerosis: Towards ontogenetic endgame?
FASEB J. 17:592–597. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Heallen T, Zhang M, Wang J,
Bonilla-Claudio M, Klysik E, Johnson RL and Martin JF: Hippo
pathway inhibits Wnt signaling to restrain cardiomyocyte
proliferation and heart size. Science. 332:458–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Hu G, Gao X, Wang Y, Zhang W,
Harmon EY, Zhi X, Xu Z, Lennartz MR, Barroso M, et al: The
induction of yes-associated protein expression after arterial
injury is crucial for smooth muscle phenotypic modulation and
neointima formation. Arterioscler Thromb Vasc Biol. 32:2662–2669.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xie C, Guo Y, Zhu T, Zhang J, Ma PX and
Chen YE: Yap1 protein regulates vascular smooth muscle cell
phenotypic switch by interaction with myocardin. J Biol Chem.
287:14598–14605. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Genevet A, Wehr MC, Brain R, Thompson BJ
and Tapon N: Kibra is a regulator of the Salvador/Warts/Hippo
signaling network. Dev Cell. 18:300–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiao L, Chen Y, Ji M, Volle DJ, Lewis RE,
Tsai MY and Dong J: KIBRA protein phosphorylation is regulated by
mitotic kinase aurora and protein phosphatase 1. J Biol Chem.
286:36304–36315. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wennmann DO, Schmitz J, Wehr MC, Krahn MP,
Koschmal N, Gromnitza S, Schulze U, Weide T, Chekuri A, Skryabin
BV, et al: Evolutionary and molecular facts link the WWC protein
family to hippo signaling. Mol Biol Evol. 31:1710–1723. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang TR, Yang G and Liu GN: DNA enzyme ED5
depletes egr-1 and inhibits neointimal hyperplasia in rats.
Cardiology. 125:192–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang W, Gao Y, Li P, Shi Z, Guo T, Li F,
Han X, Feng Y, Zheng C, Wang Z, et al: VGLL4 functions as a new
tumor suppressor in lung cancer by negatively regulating the
YAP-TEAD transcriptional complex. Cell Res. 24:331–343. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morin-Kensicki EM, Boone BN, Howell M,
Stonebraker JR, Teed J, Alb JG, Magnuson TR, O'Neal W and Milgram
SL: Defects in yolk sac vasculogenesis, chorioallantoic fusion, and
embryonic axis elongation in mice with targeted disruption of
yap65. Mol Cell Biol. 26:77–87. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
von Gise A, Lin Z, Schlegelmilch K, Honor
LB, Pan GM, Buck JN, Ma Q, Ishiwata T, Zhou B, Camargo FD and Pu
WT: YAP1, the nuclear target of Hippo signaling, stimulates heart
growth through cardiomyocyte proliferation but not hypertrophy.
Proc Natl Acad Sci USA. 109:pp. 2394–2399. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamamoto S, Yang G, Zablocki D, Liu J,
Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, et al:
Activation of mst1 causes dilated cardiomyopathy by stimulating
apoptosis without compensatory ventricular myocyte hypertrophy. J
Clin Invest. 111:1463–1474. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Odashima M, Usui S, Takagi H, Hong C, Liu
J, Yokota M and Sadoshima J: Inhibition of endogenous mst1 prevents
apoptosis and cardiac dysfunction without affecting cardiac
hypertrophy after myocardial infarction. Circ Res. 100:1344–1352.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ono H, Ichiki T, Ohtsubo H, Fukuyama K,
Imayama I, Hashiguchi Y, Sadoshima J and Sunagawa K: Critical role
of Mst1 in vascular remodeling after injury. Arterioscler Thromb
Vasc Biol. 25:1871–1876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu X, Cheng Y, Chen X, Yang J, Xu L and
Zhang C: MicroRNA-31 regulated by the extracellular regulated
kinase is involved in vascular smooth muscle cell growth via large
tumor suppressor homolog 2. J Biol Chem. 286:42371–42380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sudol M: Yes-associated protein (YAP65) is
a proline-rich phosphoprotein that binds to the SH3 domain of the
Yes proto-oncogene product. Oncogene. 9:2145–2152. 1994.PubMed/NCBI
|
|
26
|
Wang Y, Hu G, Liu F, Wang X, Wu M, Schwarz
J and Zhou J: Deletion of yes-associated protein (YAP) specifically
in cardiac and vascular smooth muscle cells reveals a crucial role
for YAP in mouse cardiovascular development. Circ Res. 114:957–965.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao B, Lei QY and Guan KL: The Hippo-YAP
pathway: New connections between regulation of organ size and
cancer. Curr Opin Cell Biol. 20:638–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao B, Tumaneng K and Guan KL: The Hippo
pathway in organ size control, tissue regeneration and stem cell
self-renewal. Nat Cell Biol. 13:877–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kudryashova TV, Goncharov DA, Pena A,
Kelly N, Vanderpool R, Baust J, Kobir A, Shufesky W, Mora AL,
Morelli AE, et al: HIPPO-integrin linked kinase cross-talk controls
self-sustaining proliferation and survival in pulmonary
hypertension. Am J Respir Crit Care Med. 194:866–877. 2016.
View Article : Google Scholar : PubMed/NCBI
|
